Literature DB >> 15477713

Complications of midgut carcinoid tumors and carcinoid syndrome.

Anouk N A van der Horst-Schrivers1, A N Machteld Wymenga, Thera P Links, Pax H B Willemse, Ido P Kema, Elisabeth G E de Vries.   

Abstract

The carcinoid syndrome, associated with carcinoid tumors of the midgut, consists of symptoms such as diarrhea, flushing, wheezing and cardiovascular symptoms. This review focuses on these symptoms and discusses therapeutic options. The symptoms are caused by the secretion of biogenic amines, polypeptides and other factors of which serotonin is the most prominent. However, diarrhea is also due to factors such as malabsorption. Besides antitumor therapy, more specific interventions such as serotonin receptor blockers can be useful. The carcinoid heart disease involves the tricuspid and pulmonary valve. In the pathogenesis, serotonin plays a central role. The therapeutic approach is mostly symptomatic. Other cardiovascular complications include bowel ischemia and hypertension. Pellagra and psychiatric symptoms are due to a depletion of tryptophan, which is consumed by the carcinoid tumor for serotonin synthesis. Finally, follow-up and clinical practice of patients with carcinoid tumors are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477713     DOI: 10.1159/000080737

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  13 in total

Review 1.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

2.  Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report.

Authors:  L Zinnamosca; L Petramala; D Cotesta; C Marinelli; S Sciomer; G Cavallaro; A Ciardi; R Massa; G De Toma; S Filetti; C Letizia
Journal:  Endocrine       Date:  2010-12       Impact factor: 3.633

Review 3.  The neurology of enteric disease.

Authors:  A J Wills; D S N A Pengiran Tengah; G K T Holmes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

4.  Antidepressants appear safe in patients with carcinoid tumor: Results of a retrospective review.

Authors:  Elie Isenberg-Grzeda; Meredith MacGregor; Afton Bergel; Stacy Eagle; Fernando Espi Forcen; Reema Mehta; Konstantina Matsoukas; Jonathan Wills; Diane Reidy-Lagunes; Yesne Alici
Journal:  Eur J Surg Oncol       Date:  2018-03-21       Impact factor: 4.424

5.  Must antidepressants be avoided in patients with neuroendocrine tumors? Results of a systematic review.

Authors:  Elie Isenberg-Grzeda; Meredith MacGregor; Konstantina Matsoukas; Ngai Chow; Diane Reidy-Lagunes; Yesne Alici
Journal:  Palliat Support Care       Date:  2020-10

6.  Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.

Authors:  W Kocha; J Maroun; H Kennecke; C Law; P Metrakos; J F Ouellet; R Reid; C Rowsell; A Shah; S Singh; S Van Uum; R Wong
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

7.  Vitamin D and vitamin B12 deficiencies are common in patients with midgut carcinoid (SI-NET).

Authors:  A Lind; B Wängberg; L Ellegård
Journal:  Eur J Clin Nutr       Date:  2016-03-30       Impact factor: 4.016

8.  Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth.

Authors:  Gianfranco Alpini; Pietro Invernizzi; Eugenio Gaudio; Julie Venter; Shelley Kopriva; Francesca Bernuzzi; Paolo Onori; Antonio Franchitto; Monique Coufal; Gabriel Frampton; Domenico Alvaro; Sum P Lee; Marco Marzioni; Antonio Benedetti; Sharon DeMorrow
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

Review 9.  Neurological disorders in adult celiac disease.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2008-11       Impact factor: 3.522

10.  Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group.

Authors:  J Maroun; W Kocha; L Kvols; G Bjarnason; E Chen; C Germond; S Hanna; P Poitras; D Rayson; R Reid; J Rivera; A Roy; A Shah; L Sideris; L Siu; R Wong
Journal:  Curr Oncol       Date:  2006-04       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.